Koninklijke Philips NV (PHIA)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account
Sell

€22.65

Buy

€22.75

arrow-up€0.41 (+1.84%)

Royal Philips NV is a health technology company. The company provides various services in the area of personal health, diagnosis and treatment, connected care and health informatics businesses, and health tech.
Prices updated at 02 May 2025, 16:40 BST
| Prices minimum 15 mins delay
|
Prices in EUR

Most recent dividend payment

0.850
Cash Dividend
12 May 2025
19 Feb 2025
13 May 2025
06 Jun 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202505101520

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.8500-
2024--
2023--
20220.7868-
20210.7868-
2020--
20190.77110.06
20180.7258-
20170.7258-
20160.7258-

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
2025-1.901.90
2024-2.472.47
2023-1.191.19
20226.0712.6518.72
20212.590.823.41
2020-1.461.46
20191.953.795.74
20182.592.535.12
20172.54-2.54
20162.76-2.76

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.250.50.751

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)202120222023202420250255075100

Dividend per share data table

YearDividend per share
20250.8500
2024-
2023-
20220.7868
20210.7868
2020-
20190.7711
20180.7258
20170.7258
20160.7258

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025-
2024-
2023-
2022-
202173.28
2020-
201958.22
201888.89
201761.54
2016197.74
Latest Financial Report as of 02 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.